UniPixel Inc (NASDAQ:UNXL), a provider of Performance Engineered Films(TM) to the touch screen, flexible printed electronics and display markets, reported on Feb 26, 2014 results for the fourth quarter and year ended December 31, 2013.Fourth Quarter 2013 Highlights, Q4 and Full Year 2013 Financial Summary Revenue totaled $11,409 in the fourth quarter of 2013, as compared to $2,030 in the fourth quarter of 2012. The marginal revenues in the fourth quarter were generated by the low-volume order delivered in December 2013. For the full year of 2013, revenue totaled $5.1 million as compared to $76,154 in 2012. The increase in 2013 was primarily due to a $5.0 million payment received by the company’s PC OEM licensee. UniPixel Inc (NASDAQ:UNXL) shares after opening at $8.00 moved to $8.20 on last trade day and at the end of the day closed at $7.63. Company price to sales ratio in past twelve months was calculated as 18.31 and price to cash ratio as 2.37. UniPixel Inc (NASDAQ:UNXL) showed a negative weekly performance of -14.46%.
KiOR Inc (NASDAQ:KIOR) has been hit on the financial front from several stakeholders. For a start, the slide-downward for the stock was some hard-selling by key insiders. KiOR Inc (NASDAQ:KIOR) saw key Insider, Stuart Peterson sell 182,900 shares he held in KIOR at an average price of $0.70 per share. This was way higher than the current trading prices for KIOR shares, as the range is largely between $0.56 and $0.69. KiOR Inc (NASDAQ:KIOR) shares advanced 6.88% in last trading session and ended the day on $0.410. KIOR return on equity ratio is recorded as -867.70% and its return on assets is -154.80%. KiOR Inc (NASDAQ:KIOR) yearly performance is -91.18%.
Onconova Therapeutics Inc (NASDAQ:ONTX) , a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, on Mar 10, 2014 provided a corporate update and reported financial results for its year ended December 31, 2013. 2013 was an important year for Onconova. During the year we completed our initial public offering and fully enrolled the Phase 3 ONTIME trial in higher risk myelodysplastic syndromes (MDS) for our lead product candidate, rigosertib.Onconova Therapeutics Inc (NASDAQ:ONTX) shares moved down -5.12% in last trading session and was closed at $6.30, while trading in range of $6.05-$6.70. Onconova Therapeutics Inc (NASDAQ:ONTX) year to date performance is -45.12%.
General Cable Corporation (NYSE:BGC) announced first quarter adjusted operating income is expected to be below the Company’s previously communicated outlook. The Company now expects to generate adjusted operating income in the range of $17 to $27 million in the first quarter of 2014. The Company’s previous outlook was $30 to $45 million. General Cable Corporation (NYSE:BGC) weekly performance is -9.28%. On last trading day company shares ended up $25.53. General Cable Corporation (NYSE:BGC) distance from 50-day simple moving average is -12.30%. Analysts mean target price for the company is $33.38.